cervical cancer

IMPACT trial: Roche’s CINtec PLUS Cytology shows higher sensitivity in detecting cervical pre-cancers in HPV-positive women compared to Pap cytology

Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by Infection…

3 years ago

The European Medicines Agency starts review of HPV vaccines to further clarify aspects of their safety profile

LONDON, 14-7-2015 — /EuropaWire/ — The European Medicines Agency (EMA) has started a review of HPV vaccines to further clarify…

9 years ago

Roche’s cobas HPV Test for first-line primary screening test for cervical cancer gets FDA approval

Expanded indication makes cobas HPV Test the only test approved in U.S. that can be used instead of Pap in…

10 years ago

Royal College of Obstetricians and Gynaecologists comments on Lancet study suggesting HPV screening provides greater protection compared to smear test

London, UK, 6-11-2013 — /EuropaWire/ — A new paper published in the Lancet (03 November) suggests that primary HPV screening provides greater protection against…

10 years ago

University of Leeds Scientists discovered new way to fight against cervical cancer

4-6-2013 — /europawire.eu/ — Scientists at the University of Leeds have found a way to target and destroy a key protein…

11 years ago